About 22,000 women in the United States are diagnosed with ovarian cancer each year. Most are asymptomatic making for a difficult diagnosis. In this program, you’ll hear from Dr. Robert Coleman, a Professor of Gynecologic Oncology at the University of Texas M. D. Anderson Cancer Center in Houston and his patient, Connie. This webcast answers questions about CA-125 and available treatment options. You’ll also hear about clinical trials, biologic and targeted therapies, RNA therapy and how the experts approach a recurrence of ovarian cancer.
Connie tells her story of finding an ovarian tumor on a routine trip to the gynecologist. Originally thought to be benign, Connie woke up from surgery to find out she had stage III ovarian cancer. Her gynecologist immediately referred her to M. D. Anderson where she met Dr. Coleman. Connie discusses how she worked with Dr. Coleman to get the appropriate treatment and enrolled in a clinical trial.
Newer drugs like Avastin and Abraxane, as well as combination therapy are helping to fight ovarian cancer. Since there is currently no effective way to detect ovarian cancer early, Dr. Coleman stresses the importance of listening to your body and getting regular check-ups. Symptoms of ovarian cancer that are often overlooked are abdominal pain, frequent urination, pelvic heaviness and abdominal bloating.
Robert Coleman, M.D.
Professor of Gynecologic Oncology, MD Anderson Cancer CenterDr. Coleman serves as Professor of Gynecologic Oncology at M.D. Anderson Cancer Center and Co-Editor of The Women’s Oncology Review and Ob/Gyn Clinical Alert. He has authored and co-authored publications including The Handbook of Gynecologic Oncology and Clinical Lymphatic Mapping in Gynecologic Cancers. His resume also includes previously serving as Division Director of Gynecologic Oncology at Creighton University School of... more >